- Home
- SBET vs QNRX Comparison
SBET vs QNRX Comparison
Compare SBET & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBET | QNRX |
|---|---|---|
| Founded | 1995 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 11.6M |
| IPO Year | 2025 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SBET | QNRX |
|---|---|---|
| Price | $5.19 | $4.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $18.71 | N/A |
| AVG Volume (30 Days) | ★ 6.9M | 29.0K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $28,055,000.00 | N/A |
| Revenue This Year | $105.19 | N/A |
| Revenue Next Year | $13.53 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 666.04 | N/A |
| 52 Week Low | $5.45 | $4.11 |
| 52 Week High | $49.52 | $41.80 |
Technical Indicators
Market Signals| Indicator | SBET | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 29.21 | 28.87 |
| Support Level | N/A | N/A |
| Resistance Level | $8.20 | $6.84 |
| Average True Range (ATR) | 0.37 | 0.47 |
| MACD | -0.11 | -0.05 |
| Stochastic Oscillator | 0.33 | 14.10 |
Price Performance
Historical ComparisonAbout SBET SharpLink Gaming Ltd.
SharpLink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.